Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Application of the 2012 revised diagnostic definitions for paediatric multiple sclerosis and immune-mediated central nervous system demyelination disorders.
Hypertrophic pachymeningitis accompanying neuromyelitis optica spectrum disorder: A case report.
Regulation of oligodendrocyte precursor maintenance by chondroitin sulphate glycosaminoglycans.
How Fatigue Influences Exercise Participation in Men With Multiple Sclerosis.
[Electrophysiological examination of multiple sclerosis].
[Neuroprotective effect screening and the mechanism of 10 kinds of coumarin derivatives].
A pilot study to improve adherence among MS patients who discontinue treatment against medical advice.
Treatment Costs and Patterns In Patients With Multiple Sclerosis Treated With Prolonged-Release Fampridine In Germany.
Experimental and Clinical Advances in Immunotherapy Strategies for Spinal Cord Injury Target on MAIs and Their Receptors.
Brain characterization using normalized quantitative magnetic resonance imaging.
Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin.
Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.
A Review of Safety-Related Pregnancy Data Surrounding the Oral Disease-Modifying Drugs for Multiple Sclerosis.
Albumin and multiple sclerosis.
Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis.
Multiple sclerosis - a dynamic field with a need for excellent education.
Demonstration of equivalence of a generic glatiramer acetate (Glatopa™).
Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis.
Correlation between Magnetic Resonance Imaging Findings and Pathological Observations in Tumefactive Multiple Sclerosis.
Progression, Symptoms and Psychosocial Concerns among Those Severely Affected by Multiple Sclerosis: A Mixed-Methods Cross-Sectional Study of Black Caribbean and White British People.
Correction to: The role of MRI in the evaluation of secondary progressive multiple sclerosis.
Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesis.
Neurofilament ELISA validation.
Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
Multiscale entropy identifies differences in complexity in postural control in women with multiple sclerosis.
Pages
« first
‹ previous
…
670
671
672
673
674
675
676
677
678
…
next ›
last »